Annual Drug Patent Expirations for LIVMARLI
Livmarli is a drug marketed by Mirum and is included in one NDA. There are two patents protecting this drug.
This drug has thirty-two patent family members in ten countries.
The generic ingredient in LIVMARLI is maralixibat chloride. Additional details are available on the maralixibat chloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
